JHS Svendgaard Laboratories Limited (NSE:JHS)
India · Delayed Price · Currency is INR 8.24
+0.02 (0.24%)
Nov 11, 2026, 2:18 PM IST
NSE:JHS Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 1,082 | 1,017 | 919.97 | 707.98 | 848.15 | 862.52 |
Other Revenue | -7.72 | 0.35 | 2.94 | 20.95 | 63.45 | 9.59 |
| 1,074 | 1,017 | 922.91 | 728.93 | 911.59 | 872.11 | |
Revenue Growth | 13.28% | 10.23% | 26.61% | -20.04% | 4.53% | -13.63% |
Cost of Revenue | 710.68 | 652.3 | 610.42 | 441.75 | 631.4 | 620.72 |
Gross Profit | 363.32 | 365 | 312.49 | 287.18 | 280.2 | 251.39 |
Selling, General & Admin | 122.31 | 117.57 | 105.06 | 97.64 | 120.49 | 117.54 |
Other Operating Expenses | 209.55 | 212.38 | 229.46 | 171.49 | 186.44 | 105.2 |
Operating Expenses | 405.9 | 404.9 | 421.24 | 332.59 | 367.1 | 293.26 |
Operating Income | -42.58 | -39.91 | -108.75 | -45.42 | -86.9 | -41.87 |
Interest Expense | -10.52 | -8.02 | -4.72 | -4.25 | -4.98 | -12.7 |
Interest & Investment Income | 14.83 | 14.83 | 12.24 | 5.61 | 9.9 | 21.99 |
Currency Exchange Gain (Loss) | 1.83 | 1.83 | 0.04 | -1.2 | 9 | 6.53 |
Other Non Operating Income (Expenses) | -3.51 | 0.82 | 0.49 | 1.15 | 133.33 | 5.15 |
EBT Excluding Unusual Items | -39.95 | -30.44 | -100.71 | -44.1 | 60.35 | -20.9 |
Gain (Loss) on Sale of Investments | 4.58 | 4.58 | 3.63 | 2.85 | 0.7 | 1.53 |
Gain (Loss) on Sale of Assets | 0.9 | 0.9 | 0.59 | 0.02 | 25.4 | 15 |
Asset Writedown | - | - | -28.59 | - | - | - |
Other Unusual Items | 2.06 | 2.06 | - | 6.95 | -183.62 | 5.4 |
Pretax Income | -32.41 | -22.91 | -125.08 | -34.29 | -97.18 | 1.03 |
Income Tax Expense | -20.58 | -3.68 | 72.37 | 6.29 | -54.28 | 43.92 |
Earnings From Continuing Operations | -11.83 | -19.22 | -197.44 | -40.58 | -42.89 | -42.89 |
Minority Interest in Earnings | - | - | - | - | 2.37 | 2.37 |
Net Income | -11.83 | -19.22 | -197.44 | -40.58 | -40.52 | -40.52 |
Net Income to Common | -11.83 | -19.22 | -197.44 | -40.58 | -40.52 | -40.52 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 85 | 86 | 83 | 78 | 78 | 64 |
Shares Outstanding (Diluted) | 85 | 89 | 83 | 78 | 78 | 64 |
Shares Change | -7.89% | 6.93% | 6.07% | - | 21.89% | 4.34% |
EPS (Basic) | -0.14 | -0.22 | -2.37 | -0.52 | -0.52 | -0.63 |
EPS (Diluted) | -0.14 | -0.22 | -2.37 | -0.52 | -0.52 | -0.63 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -214.92 | -114.72 | -157.11 | -407.1 | 89.43 | -158.75 |
Free Cash Flow Per Share | -2.53 | -1.29 | -1.89 | -5.19 | 1.14 | -2.47 |
Gross Margin | 33.83% | 35.88% | 33.86% | 39.40% | 30.74% | 28.83% |
Operating Margin | -3.96% | -3.92% | -11.78% | -6.23% | -9.53% | -4.80% |
Profit Margin | -1.10% | -1.89% | -21.39% | -5.57% | -4.45% | -4.65% |
Free Cash Flow Margin | -20.01% | -11.28% | -17.02% | -55.85% | 9.81% | -18.20% |
EBITDA | 25.91 | 29.51 | -35.54 | 12.81 | -26.74 | 28.65 |
EBITDA Margin | 2.41% | 2.90% | -3.85% | 1.76% | -2.93% | 3.28% |
D&A For EBITDA | 68.49 | 69.41 | 73.21 | 58.22 | 60.17 | 70.52 |
EBIT | -42.58 | -39.91 | -108.75 | -45.42 | -86.9 | -41.87 |
EBIT Margin | -3.96% | -3.92% | -11.78% | -6.23% | -9.53% | -4.80% |
Effective Tax Rate | - | - | - | - | - | 4264.47% |
Revenue as Reported | 1,108 | 1,051 | 948.74 | 751.13 | 961.36 | 956.42 |
Advertising Expenses | - | 3.95 | 3.4 | 2.85 | 17.79 | 2.44 |